- Home
- REE vs ENLV Comparison
REE vs ENLV Comparison
Compare REE & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REE
- ENLV
- Stock Information
- Founded
- REE 2011
- ENLV 2005
- Country
- REE Israel
- ENLV Israel
- Employees
- REE N/A
- ENLV N/A
- Industry
- REE Auto Manufacturing
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- REE Consumer Discretionary
- ENLV Health Care
- Exchange
- REE Nasdaq
- ENLV Nasdaq
- Market Cap
- REE 22.4M
- ENLV 26.6M
- IPO Year
- REE N/A
- ENLV 1995
- Fundamental
- Price
- REE $0.74
- ENLV $0.90
- Analyst Decision
- REE Strong Buy
- ENLV Strong Buy
- Analyst Count
- REE 2
- ENLV 2
- Target Price
- REE $11.75
- ENLV $10.00
- AVG Volume (30 Days)
- REE 129.4K
- ENLV 130.5K
- Earning Date
- REE 12-16-2025
- ENLV 11-28-2025
- Dividend Yield
- REE N/A
- ENLV N/A
- EPS Growth
- REE N/A
- ENLV N/A
- EPS
- REE N/A
- ENLV N/A
- Revenue
- REE $183,000.00
- ENLV N/A
- Revenue This Year
- REE $327.73
- ENLV N/A
- Revenue Next Year
- REE $36,888.82
- ENLV N/A
- P/E Ratio
- REE N/A
- ENLV N/A
- Revenue Growth
- REE N/A
- ENLV N/A
- 52 Week Low
- REE $0.53
- ENLV $0.81
- 52 Week High
- REE $11.72
- ENLV $2.10
- Technical
- Relative Strength Index (RSI)
- REE 37.61
- ENLV 26.28
- Support Level
- REE $0.66
- ENLV $1.03
- Resistance Level
- REE $0.99
- ENLV $1.00
- Average True Range (ATR)
- REE 0.11
- ENLV 0.04
- MACD
- REE -0.02
- ENLV -0.01
- Stochastic Oscillator
- REE 22.23
- ENLV 27.70
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.